Jubilant Pharmova Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:	530019	NSE Symbol:	JUBLPHARMA	P/E :	0
ISIN Demat:	INE700A01033	Div & Yield %:	0.46	EPS :	0
Book Value:	140.87	Market Cap (Rs. Cr.):	17,282.46	Face Value :	1

Date	Headline
02-Dec-25	Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
31-Oct-25	Board of Jubilant Pharmova approves grant of 1,506 stock options
15-Oct-25	Jubilant Pharmova to discuss results
10-Oct-25	Jubilant HollisterStier expands its sterile injectable manufacturing capacity at Spokane unit in the
07-Aug-25	Jubilant Pharmova AGM scheduled
02-Aug-25	USFDA concludes pre-approval inspection of Jubilant Generics' Roorkee site
29-Jul-25	Jubilant Pharmova CFO resigns
23-Jul-25	Jubilant Pharmova schedules board meeting
16-May-25	Board of Jubilant Pharmova recommends final dividend
02-May-25	Jubilant Pharmova to hold board meeting

Company Snapshot